Eric Warren Esperion Therapeutics, Inc. (ESPR) insider trading activity

ESPR Quotes by TradingView

Eric Warren is Chief Commercial Officer of Esperion Therapeutics, Inc.. Currently has a direct ownership of 160,121 shares of ESPR, which is worth approximately $344,260. The most recent transaction as insider was on Mar 14, 2022, when has been sold 13,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 160K
1.56% 3M change
134.38% 12M change
Total Value Held $344,260

Eric Warren Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 14 2022
BUY
Grant, award, or other acquisition
-
13,000 Added 19.37%
54,106 Common Stock
EW

Eric Warren

Chief Commercial Officer
Ann Arbor, MI

Track Institutional and Insider Activities on ESPR

Follow Esperion Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ESPR shares.

Notify only if

Insider Trading

Get notified when an Esperion Therapeutics, Inc. insider buys or sells ESPR shares.

Notify only if

News

Receive news related to Esperion Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ESPR